Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rap 1B Inhibitors

Rap1B inhibitors represent a class of chemical compounds designed to target and modulate the activity of Rap1B, a member of the Ras superfamily of small GTPases. Rap1B plays a crucial role in intracellular signaling pathways by regulating various cellular processes, including cell adhesion, migration, and differentiation. These inhibitors are developed with the intent to selectively interfere with Rap1B's signaling capabilities, primarily by inhibiting its activation through the exchange of GDP (guanosine diphosphate) for GTP (guanosine triphosphate). By doing so, they aim to disrupt downstream signaling cascades initiated by Rap1B activation.

The development of Rap1B inhibitors is driven by the need to unravel the intricacies of cellular signaling pathways and their involvement in fundamental biological processes. Researchers employ these compounds as valuable tools in both basic science and translational research to investigate the role of Rap1B in various cellular contexts. By selectively inhibiting Rap1B, scientists can elucidate its specific contributions to cell physiology and its potential implications in cellular functions and diseases. The study of Rap1B inhibitors holds promise for advancing our understanding of cell signaling networks and may lead to insights into novel research areas and potential applications in the future.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a ROCK inhibitor that may indirectly reduce Rap1B expression by altering actin cytoskeleton dynamics and cellular signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, potentially leading to decreased Akt signaling and subsequent reductions in Rap1B expression.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 specifically inhibits p38 MAPK, potentially altering downstream signaling and reducing Rap1B expression.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 inhibits MEK, potentially leading to reduced MAPK signaling and decreased Rap1B expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which could lead to reduced protein synthesis and potentially decreased Rap1B expression.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a PI3K inhibitor, potentially leading to reduced Akt signaling and subsequent reductions in Rap1B expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, which might alter cellular signaling pathways and lead to decreased Rap1B expression.

LY3214996

1951483-29-6sc-507299
5 mg
$265.00
(0)

LY3214996 specifically inhibits ERK1/2, potentially leading to alterations in signaling pathways and reduced Rap1B expression.

GW 5074

220904-83-6sc-200639
sc-200639A
5 mg
25 mg
$106.00
$417.00
10
(1)

GW5074 is a c-Raf inhibitor, potentially influencing MAPK signaling pathways and leading to decreased Rap1B expression.